Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Mineralocorticoid receptor antagonists's trials
EMRACHH
Effect of MRA on Cardiovascular Disease in Patients With Hypertension and Hyperaldosteronemia
Mineralocorticoid Receptor Antagonists(MRAs)
Ongoing
Enrolling by invitation
Phase 4
Open NCT05688579 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
